Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colloidal sulfur is a finely dispersed form of elemental sulfur (S) with a molecular weight of 32.07. It is widely used in cosmetics and dermatological products for its antimicrobial, anti-inflammatory, keratolytic (exfoliating), and sebum-regulating properties[1][2][3][4][6]. In skincare formulations—especially those targeting acne—it helps clear excess keratin and sebum from pores, inhibits the growth of bacteria and fungi on the skin surface, reduces inflammation associated with acne lesions, and promotes healing of damaged skin barriers[3][4][5]. Colloidal sulfur is generally considered milder than traditional precipitated or sublimed sulfur due to its smaller particle size and encapsulation technologies (e.g., microencapsulation with acacia gum or collagen), which improve stability and reduce irritation[3][6]. It is not systemically absorbed when used topically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on colloidal sulfur.